E Fund Management (HK)’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
E Fund Management (HK)'s NVS Position: Q2 2026 in Review
E Fund Management (HK) increased its Novartis (NVS) stake by 53% in Q2 2026, buying an estimated $7.2K and bringing the position to 138 shares worth $21.6K. The position accounts for 0.01% of the portfolio, ranked #304.
E Fund Management (HK) first reported a position in NVS in Q1 2026 and has held it in 2 quarters since. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- E Fund Management (HK) held 138 shares of Novartis worth $21.6K as of Q2 2026.
- E Fund Management (HK) bought 48 Novartis shares in Q2 2026, an estimated $7.2K.
- Novartis made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #304 holding.
- E Fund Management (HK) first reported a position in Novartis in Q1 2026 and has held it in 2 quarters since.
- 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.